The association between depression and coronary artery calcification: A meta-analysis of observational studies

Song Lin1, Huaqi Zhang1, Aiguo Ma1

  • 1The College of Public Health, Qingdao University, 38 Dengzhou Road, Qingdao, Shandong 266021, China.

Insights

Diagnosed depression is linked to a higher likelihood of coronary artery calcification (CAC). This meta-analysis suggests screening for CAC in depressed patients to assess cardiovascular disease risk.

Area of Science:

  • Cardiology
  • Psychiatry
  • Epidemiology

Background:

  • Cardiovascular diseases and depression represent a significant global health burden.
  • The relationship between depression and coronary artery calcification (CAC) is not well-established.
  • A quantitative meta-analysis on this association was lacking.

Purpose of the Study:

  • To evaluate the association between depression and coronary artery calcification (CAC).
  • To provide a quantitative synthesis of existing observational studies.

Main Methods:

  • A systematic literature search was conducted across major databases (PubMed, Web of Science, Embase, etc.) up to April 2017.
  • Included 15 observational studies with 32,884 participants.
  • Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using a random effects model, including subgroup analyses.

Main Results:

  • A significant positive association was found between diagnosed depression and CAC (OR = 1.15; 95% CI: 1.04-1.28).
  • No significant association was observed between depressive symptoms and CAC (OR = 1.02; 95% CI: 0.97-1.07).
  • Subgroup analysis of cohort studies showed an enhanced positive association for diagnosed depression and CAC (OR = 2.20; 95% CI: 1.33-3.64).

Conclusions:

  • Diagnosed depression is associated with increased odds of coronary artery calcification (CAC).
  • Systematic screening for CAC may benefit clinically depressed individuals.
  • Identifying high-risk patients can aid in preventing future cardiovascular diseases.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
540
Observational Studies01:11

Observational Studies

Observational studies are a type of analytical study where researchers observe events without any interventions. In other words, the researcher does not influence the response variable or the experiment's outcome.
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
11.1K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
303
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
424
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
735